Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
NACRES:
NA.85
UNSPSC Code:
41171614
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
sterility
sterile (Filtered and Aseptic Handled)
form
liquid
shelf life
limited shelf life, expiry date on the label
packaging
vial of 50 mL
application(s)
clinical testing
environmental
food and beverages
life science and biopharma
veterinary, microbiology
storage temp.
2-8°C
suitability
mycobacteria
General description
Middlebrook OADC Growth Supplement is used with the Middlebrook Agar, that allows the isolation and cultivation of a wide variety of Mycobacteria. Middlebrook OADC Growth Supplement contains oleic acid, bovine albumin, sodium chloride, dextrose, and catalase. Oleic acid and other long chain fatty acids are essential for the metabolism of Mycobacteria. Some free fatty acids are toxic to Mycobacteria, but albumin binds to those fatty acids and prevents toxic action on Mycobacteria. Dextrose is the fermentable carbohydrate and an energy source whereas catalase destroys toxic peroxides that may be present in the medium.
Application
Middlebrook OADC growth supplement has been used as a supplement in 7H9 liquid medium to culture mycobacteria from clinical samples, environmental, food and beverages.
Other Notes
Ingredients: (per vial)
Bovine Albumin Fraction V 2.50 g
Dextrose 1.00 g
Catalase 0.002 g
Oleic acid 0.025 g
Sodium chloride 0.425 g
Distilled water 50 mL
Bovine Albumin Fraction V 2.50 g
Dextrose 1.00 g
Catalase 0.002 g
Oleic acid 0.025 g
Sodium chloride 0.425 g
Distilled water 50 mL
Clase de almacenamiento
12 - Non Combustible Liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
Soto JA, et al.
Frontiers in immunology, 9 (2018)
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
Soto JA, et al.
Frontiers in Immunology, 9 (2018)
Detecting phenotypically resistant Mycobacterium tuberculosis using wavelength modulated Raman spectroscopy
Antibiotic resistance protocols, 41-50 (2018)